As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if ...
There is profound transformation coming over the next decades. It will unlock the equivalent of a century of change every ...
Allonnia, the bio-ingenuity company that develops scalable solutions to improve mineral recovery and reduce environmental ...
The incidence of HPV16-related cancers is rapidly increasing in the US and Europe and also increasing globally.* PDS0101 is currently being studied in the Company’s Phase 3 trial for PDS0101 + ...
Undecided with Matt Ferrell on MSN
The future of concrete: is graphene the answer?
Is Graphene the Future of Eco-Friendly Concrete? This video explores graphene, a major breakthrough in material science, and ...
TipRanks on MSN
NexGel Inc announces spin-off of drug delivery unit
An announcement from NexGel Inc ( ($NXGL) ) is now available. On December 11, 2025, NEXGEL, Inc. announced the spin-off of its drug delivery ...
An enzyme found in papaya could lead to new medicines: a scientific review reveals the surprising pharmaceutical potential of papain.
The publication, titled “Prime Editing for p47-phox Chronic Granulomatous Disease,” reports initial data for two patients treated in the Phase 1/2 trial of PM359, which was designed to assess safety, ...
It’s the Trump administration’s latest push to increase pressure on Venezuelan President Nicolás Maduro, who has been charged ...
The Alltech Celebration of Song was inspired by Dr. Pearce Lyons’ dream of bringing a Brazilian tradition to Kentucky.
Recently, The Kuni Foundation sponsored a conversation with the Portland Business Journal about the challenges and ...
—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results